Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry

نویسندگان

  • Juan Ignacio Rojas
  • Liliana Patrucco
  • Maria Trojano
  • Alessandra Lugaresi
  • Guillermo Izquierdo
  • Helmut Butzkueven
  • Vilija Jokubaitis
  • Pierre Duquette
  • Marc Girard
  • Francois Grand’Maison
  • Pierre Grammond
  • Celia Oreja-Guevara
  • Raymond Hupperts
  • Cavit Boz
  • Thor Petersen
  • Roberto Bergamaschi
  • Giorgio Giuliani
  • Jeannette Lechner-Scott
  • Michael Barnett
  • Maria Edite Rio
  • Vincent Van Pesch
  • Maria Pia Amato
  • Gerardo Iuliano
  • Marcela Fiol
  • Mark Slee
  • Freek Verheul
  • Ricardo Fernandez-Bolanos
  • Dieter Poehlau
  • Maria Laura Saladino
  • Leontien Den Braber-Moerland
  • Norma Deri
  • Walter Oleschko-Arruda
  • Jose Antonio Cabrera-Gomez
  • Mark Paine
  • Norbert Vella
  • Ilya Kister
  • Eli Skromne
  • Aldo Savino
  • Cameron Shaw
  • Fraser Moore
  • Steve Vucic
  • Tatjana Petkovska-Boskova
  • Elizabeth Alejandra Bacile Bacile
  • Vetere Santiago
  • Edgardo Cristiano
چکیده

Limited data suggest that multiple sclerosis (MS) in Latin America (LA) could be less severe than in the rest of the world. The objective was to compare the course of MS between LA and other regions. METHODS Centers from 18 countries with >20 cases enrolled in the MSBase Registry participated. Patients with MS with a disease duration of >1 year and <30 years at time of EDSS measurement were evaluated. The MS Severity Score (MSSS) was used as a measure of disease progression. Comparisons among regions (North America, Europe, Australia and LA), hemispheres and countries were performed. RESULTS A total of 9610 patients were included. Patients were from: Europe, 6290 (65.6%); North America, 1609 (16.7%); Australia, 1119 (11.6%); and LA, 592 (6.1%). The mean MSSS in patients from LA was 4.47 ± 2.8, 4.53 ± 2.8 in North America, 4.51 ± 2.8 in Europe and 4.49 ± 2.7 in Australia. Mean MSSS in the northern hemisphere was 4.51 ± 1.6 compared to 4.48 ± 1.9 in the southern hemisphere. No differences were found for MSSS among hemispheres (p = 0.68), regions (p = 0.96) or countries (p = 0.50). CONCLUSIONS Our analyses did not discover any difference in mean MSSS among patients from different regions, hemispheres or countries.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Polymorphisms in the Apolipoprotein E Region and Severity of Multiple Sclerosis

Background: The apolipoprotein E (APOE) polymorphism is known to affect various neurologic disorders with different effects on the immune system and CNS repair. However, previous studies on possible modulation of the clinical course of multiple sclerosis (MS) by APOE polymorphism have been inconsistent. Objective: To clarify the issue for MS patients' management and future research. Methods: Th...

متن کامل

Effects of Estrogen and Progesterone on Different Immune Cells Related to Multiple Sclerosis

Multiple Sclerosis (MS) is a chronic autoimmune disease of young adults with an unknown etiology, but cellular immune responses and inflammation has a pivotal role in this regard. The higher incidence of MS among women indicates the possible involvement of female sex hormones on the disease course. Progesterone and estrogen are the most important sexual hormones in women. They exert different i...

متن کامل

The effect of telephone consultation and follow-up on pain reduction in Multiple Sclerotic patients: a randomized clinical trial

Introduction: pain is one the symptoms from which many patients with Multiple Sclerosis (MS) suffer. Provision of advice and care to patients with chronic diseases, such as MS, through the counseling process accompanied by telephone follow-up may prove effective in alleviating disease-related symptoms. Hence, the current study was carried out to determine the impact of telephone counseling and ...

متن کامل

A Report of Multiple Sclerosis Registry in Mazandaran Province 2019-2021

 Background and purpose: Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system. The purpose of this study was to report the information of MS patients registered in Mazandaran MS Registry System between 2019 and 2021. Materials and methods: This retrospective study was performed in patients with MS living in Mazandaran province using the ...

متن کامل

P 153: Neuroinflammation in Multiple Sclerosis

Multiple sclerosis (MS) is a complex disease which is correlated with increasing inflammatory factors, demyelination and axonal loss. In this auto-immune disease, Neuroinflammation is mediated by different types of T cells with macrophage/microglial activation and B cells involvement that interact in a collaborative manner. Focal inflammation is the main cause for the onset of relapses and coul...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 1  شماره 

صفحات  -

تاریخ انتشار 2015